Cargando…

Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014

Aims: The study assessed the quality of diagnosis and staging offered to patients with a head and neck squamous cell carcinoma (HNSCC) and the variability across Belgian hospitals. Methods: In total, 9,245 patients diagnosed with HNSCC between 2009 and 2014, were identified in the population-based B...

Descripción completa

Detalles Bibliográficos
Autores principales: Leroy, Roos, De Gendt, Cindy, Stordeur, Sabine, Schillemans, Viki, Verleye, Leen, Silversmit, Geert, Van Eycken, Elizabeth, Savoye, Isabelle, Grégoire, Vincent, Nuyts, Sandra, Vermorken, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794682/
https://www.ncbi.nlm.nih.gov/pubmed/31649876
http://dx.doi.org/10.3389/fonc.2019.01006
_version_ 1783459342816641024
author Leroy, Roos
De Gendt, Cindy
Stordeur, Sabine
Schillemans, Viki
Verleye, Leen
Silversmit, Geert
Van Eycken, Elizabeth
Savoye, Isabelle
Grégoire, Vincent
Nuyts, Sandra
Vermorken, Jan
author_facet Leroy, Roos
De Gendt, Cindy
Stordeur, Sabine
Schillemans, Viki
Verleye, Leen
Silversmit, Geert
Van Eycken, Elizabeth
Savoye, Isabelle
Grégoire, Vincent
Nuyts, Sandra
Vermorken, Jan
author_sort Leroy, Roos
collection PubMed
description Aims: The study assessed the quality of diagnosis and staging offered to patients with a head and neck squamous cell carcinoma (HNSCC) and the variability across Belgian hospitals. Methods: In total, 9,245 patients diagnosed with HNSCC between 2009 and 2014, were identified in the population-based Belgian Cancer Registry (BCR). The BCR data were coupled with other databases providing information on diagnostic and therapeutic procedures reimbursed by the compulsory health insurance, vital status data, and comorbidities. The use of diagnosis and staging procedures was assessed by four quality indicators (QI) (i.e., use of dedicated head and neck imaging studies, use of PET-CT, TNM reporting and interval between diagnosis and start of treatment), for which a target was defined before the analysis. The association between the binary QIs and observed survival was assessed using Cox proportional hazard models adjusted for potential confounders. Results: Overall, 82.5% of patients received staging by MRI and/or CT of the head and neck region before the start of treatment. In 47.6% of stage III–IV patients eligible for treatment with curative intent, a whole-body FDG-PET(/CT) was performed. The proportion of patients whose cTNM and pTNM stage was reported to the BCR was 80.5 and 78.4%, respectively. The median interval from diagnosis to first treatment with curative intent was 32 days (IQR: 19–46). For none of these QIs the pre-set targets were reached and a substantial variability between centers was observed for all quality indicators. No binary QI was significantly associated with observed survival. Conclusions: The four quality indicators related to diagnosis and staging in HNSCC all showed substantial room for improvement. For none of them the pre-set targets were met at the national level and the variability between centers was substantial. Each Belgian hospital received an individual feedback report in order to stimulate reflection and quality improvement processes.
format Online
Article
Text
id pubmed-6794682
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67946822019-10-24 Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014 Leroy, Roos De Gendt, Cindy Stordeur, Sabine Schillemans, Viki Verleye, Leen Silversmit, Geert Van Eycken, Elizabeth Savoye, Isabelle Grégoire, Vincent Nuyts, Sandra Vermorken, Jan Front Oncol Oncology Aims: The study assessed the quality of diagnosis and staging offered to patients with a head and neck squamous cell carcinoma (HNSCC) and the variability across Belgian hospitals. Methods: In total, 9,245 patients diagnosed with HNSCC between 2009 and 2014, were identified in the population-based Belgian Cancer Registry (BCR). The BCR data were coupled with other databases providing information on diagnostic and therapeutic procedures reimbursed by the compulsory health insurance, vital status data, and comorbidities. The use of diagnosis and staging procedures was assessed by four quality indicators (QI) (i.e., use of dedicated head and neck imaging studies, use of PET-CT, TNM reporting and interval between diagnosis and start of treatment), for which a target was defined before the analysis. The association between the binary QIs and observed survival was assessed using Cox proportional hazard models adjusted for potential confounders. Results: Overall, 82.5% of patients received staging by MRI and/or CT of the head and neck region before the start of treatment. In 47.6% of stage III–IV patients eligible for treatment with curative intent, a whole-body FDG-PET(/CT) was performed. The proportion of patients whose cTNM and pTNM stage was reported to the BCR was 80.5 and 78.4%, respectively. The median interval from diagnosis to first treatment with curative intent was 32 days (IQR: 19–46). For none of these QIs the pre-set targets were reached and a substantial variability between centers was observed for all quality indicators. No binary QI was significantly associated with observed survival. Conclusions: The four quality indicators related to diagnosis and staging in HNSCC all showed substantial room for improvement. For none of them the pre-set targets were met at the national level and the variability between centers was substantial. Each Belgian hospital received an individual feedback report in order to stimulate reflection and quality improvement processes. Frontiers Media S.A. 2019-10-09 /pmc/articles/PMC6794682/ /pubmed/31649876 http://dx.doi.org/10.3389/fonc.2019.01006 Text en Copyright © 2019 Leroy, De Gendt, Stordeur, Schillemans, Verleye, Silversmit, Van Eycken, Savoye, Grégoire, Nuyts and Vermorken. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Leroy, Roos
De Gendt, Cindy
Stordeur, Sabine
Schillemans, Viki
Verleye, Leen
Silversmit, Geert
Van Eycken, Elizabeth
Savoye, Isabelle
Grégoire, Vincent
Nuyts, Sandra
Vermorken, Jan
Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014
title Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014
title_full Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014
title_fullStr Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014
title_full_unstemmed Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014
title_short Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014
title_sort head and neck cancer in belgium: quality of diagnostic management and variability across belgian hospitals between 2009 and 2014
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794682/
https://www.ncbi.nlm.nih.gov/pubmed/31649876
http://dx.doi.org/10.3389/fonc.2019.01006
work_keys_str_mv AT leroyroos headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014
AT degendtcindy headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014
AT stordeursabine headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014
AT schillemansviki headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014
AT verleyeleen headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014
AT silversmitgeert headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014
AT vaneyckenelizabeth headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014
AT savoyeisabelle headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014
AT gregoirevincent headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014
AT nuytssandra headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014
AT vermorkenjan headandneckcancerinbelgiumqualityofdiagnosticmanagementandvariabilityacrossbelgianhospitalsbetween2009and2014